News

NeoGenomics (NASDAQ:NEO) Misses Q4 Sales Targets

Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 10.6% year on year to $172 million. On the other hand, the company’s full-year revenue guidance of $740 million at the midpoint came in 0.7% above analysts’ estimates. Its non-GAAP profit of $0.04 per share was $0.01 above analysts’ consensus estimates.

S&P 500 ekes out all-time closing high as Fed minutes eyed

The S&P 500 squeaked past its previous record closing high on Tuesday at the top of a holiday-shortened week, with earnings season winding down, U.S. Federal Reserve minutes on tap, and geopolitical uncertainties churning in the background. "There's a little bit of a three-day weekend hangover today," said Ryan Detrick, chief market strategist at Carson Group in Omaha. "At the same time we have the Fed minutes, coming out tomorrow and big retail earnings also coming out later this week," Detrick added.

Treasury Yields Climb as Traders Seek Further Clues on Fed Path

(Bloomberg) -- Treasuries slipped as traders sought further guidance on the path of US interest rates following economic reports last week that muddied their assessment of price pressures.Most Read from BloombergWhy Barcelona Bought the Building That Symbolizes Its Housing CrisisPor qué Barcelona compró el edificio que simboliza su crisis inmobiliariaTrump Child Refugee Agency Shares Data With Immigration EnforcersA Filmmaker’s Surreal Journey Into His Own Private WinnipegNYC Restaurants Are Sti